An estimated 6 to 8 million Americans are living with metabolic dysfunction-associated steatohepatitis, or MASH, the most ...

A new type of cell therapy which could offer “real hope” to patients with advanced liver disease has been welcomed by a liver charity. Researchers said results from a clinical trial suggest that the ...

Nowadays, due to changing lifestyles, irregular eating habits, and lack of exercise, the problem of fatty liver is rapidly ...

A new drug has cured 20% of patients with a chronic, cancer-causing disease — which was previously incurable. A viral ...

"University of Edinburgh develops cell therapy for liver disease" was originally created and published by Pharmaceutical ...

Scientists at UC San Diego have unveiled a potentially game-changing treatment for MASH, a severe fatty liver disease ...

Fatty liver disease can be spotted early by noticing certain signs in your eyes. Dr Vinit Shah explains how the disease can ...

Different types of liver disease are leading to distinct signatures of muscle loss, according to a new study that could help ...

The sneaky virus poses serious health threats if it goes on to become a chronic disease. Clinical trial results suggest a new drug may cure 1 in 5 of those cases.

Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today ...

A clinical trial of more than 3,600 patients evaluated for chest pain showed that fatty liver disease was linked to nearly ...

It's "not only a liver condition but also an important marker of heart disease risk,” says one of the study's authors.